Pfizer · 3 weeks ago
Postdoctoral Fellow in AI/ML Applications for Vaccine Research & Development
Pfizer is a leading biopharmaceutical company dedicated to delivering breakthroughs that transform patients' lives. In this role, you will develop advanced AI and machine learning models for vaccine research, collaborating with multidisciplinary teams to enhance vaccine development processes.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Develop advanced AI and machine learning models, including transformer architectures and graph neural networks, to represent molecular features and predict immunogenicity of pneumococcal conjugate vaccines using preclinical and clinical data
Apply transfer learning to translate predictive models from preclinical to clinical domains and utilize interpretation frameworks (such as SHAP) to identify key molecular motifs for rational vaccine design
Conduct meta-analyses of large-scale immunogenicity datasets to characterize quantitative relationships between vaccine physical parameters and immunogenicity outcomes
Harmonize and curate preclinical and clinical datasets to support robust statistical and machine learning analyses
Engage in active collaboration with multidisciplinary teams, encompassing experts in data science, preclinical analysis, and clinical vaccine research, to advance pneumococcal conjugate vaccines development
Publish impactful scientific findings while safeguarding confidential data, ensuring clear, transparent reporting of methods and results to facilitate reproducibility and recognition in peer-reviewed journals and conferences
Qualification
Required
Ph.D. in Computational Biology, Bioinformatics, Computer Science, Immunology, or a related field
Successful record of scientific accomplishments evidenced by scientific publications and/or presentations with at least one first-author publication in a peer-reviewed journal
No more than 2 years of post-degree experience
Willingness to make a minimum 2-year commitment
Demonstrated expertise in machine learning and deep learning, with hands-on experience in developing and validating predictive models for biological or biomedical data
Proficiency in Python and relevant AI Machine Learning frameworks (e.g., PyTorch, TensorFlow, scikit-learn). Experience with statistical modeling, including regression analysis and mixed-effects models
Solid understanding of immunology, especially vaccine immunogenicity and conjugate vaccine design
Strong data management and curation skills, including harmonization of heterogeneous biological datasets
Excellent scientific communication skills, with a track record of peer-reviewed publications or presentations. Ability to work across computational and wet‑lab teams, distill complex results for diverse stakeholders
Preferred
Prior experience applying graph neural networks, transformer models, or cross-attention mechanisms to biological sequence or molecular structure data
Familiarity with glycan-focused modeling and representation, including encoding of polysaccharide and protein carrier features
Experience in translational research bridging preclinical and clinical datasets, especially in vaccine development
Knowledge of SHAP or similar model interpretation frameworks for feature attribution in complex models
Hands-on experience with ensemble modeling and transfer learning in biomedical contexts
Collaborative experience with experimental biologists and vaccine R&D teams
Familiarity with regulatory and translational aspects of vaccine development
Benefits
401(k) plan with Pfizer Matching Contributions
Pfizer Retirement Savings Contribution
Paid vacation
Holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage
Company
Pfizer
Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.
Funding
Current Stage
Public CompanyTotal Funding
$38BKey Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B
Recent News
Longevity.Technology
2026-01-09
Company data provided by crunchbase